# Second Dose of Varicella Vaccine in Healthy Children

> **NCT07475000** · PHASE3 · RECRUITING · sponsor: **Sinovac (Dalian) Vaccine Technology Co., Ltd.** · enrollment: 300 (estimated)

## Conditions studied

- Varicella (Chickenpox)
- Varicella Immunisation

## Interventions

- **BIOLOGICAL:** PROVARIX

## Key facts

- **NCT ID:** NCT07475000
- **Lead sponsor:** Sinovac (Dalian) Vaccine Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-28
- **Primary completion:** 2026-07-15
- **Final completion:** 2026-11-15
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07475000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07475000, "Second Dose of Varicella Vaccine in Healthy Children". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07475000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*